Sinergia Empresarial
Inicio/Internacional
Internacional

Samsung Biologics buys Swiss peptide maker for $1.8bn

PolyPeptide takeover is latest example of South Korean companies expanding abroad through acquisitions

Por Redacción Sinergia Empresarial · 20 de julio de 2026 · 1 min
Samsung Biologics buys Swiss peptide maker for $1.8bn

PolyPeptide takeover is latest example of South Korean companies expanding abroad through acquisitions

Sinergia Empresarial continuará el seguimiento de esta información sobre samsung Biologics buys Swiss peptide maker for $1.8bn y ampliará la cobertura conforme se confirmen nuevos elementos relevantes para el ecosistema empresarial.

Sigue leyendo

Más en Internacional

London Stock Exchange plans to launch round-the-clock trading next yearInternacional

London Stock Exchange plans to launch round-the-clock trading next year

London Stock Exchange plans to launch round-the-clock trading next year. New overnight venue will initially offer access to exchange-traded products

20 de julio de 2026 · 1 min
JPMorgan Chase boss warns Andy Burnham of 'consequences' if he taxes banksInternacional

JPMorgan Chase boss warns Andy Burnham of 'consequences' if he taxes banks

Jamie Dimon says any tax raid by new UK prime minister would threaten bank's planned £3bn London office

20 de julio de 2026 · 1 min
Oracle could face $7bn collateral bill for Wisconsin data centreInternacional

Oracle could face $7bn collateral bill for Wisconsin data centre

Increased power costs add to challenges facing tech giant's AI ambition amid high spending and mounting debt

20 de julio de 2026 · 1 min